Hypertension in pregnancy is an emerging sex-specific risk factor for cardiovascular disease and may lead to more severe hypertension after pregnancy. The objectives of this study were to investigate the frequency of pregnancy-related hypertension among patients referred to a hypertension clinic and its association with the severity of hypertension and evidence of end-organ damage. In this cross-sectional study, women with hypertension were submitted to a systematic clinical evaluation. The occurrence of pregnancy-related hypertension was investigated by questionnaire. The association between pregnancy-related hypertension and severity of hypertension (stage 2 according to Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII)) and end-organ damage was assessed in a logistic regression model. The mean age, systolic and diastolic blood pressure and body mass index (BMI) of the 768 women examined were 51.6 ± 12.7 years, 158.2 ± 26.6 mm Hg, 93.8 ± 14.3 mm Hg and 29.4±5.6 kg/m 2 , respectively. The proportion of women with pregnancy-related hypertension was 32.9%. It was significantly associated with hypertension at stage 2 (OR: 1.60, 95% CI: 1.14-2.24; P ¼ 0.01) after controlling for confounders. The occurrence of a pregnancy-related hypertension was not associated with evidence of optic fundi abnormalities, left ventricular hypertrophy or abnormalities in kidney function. In conclusion, pregnancy-related hypertension is frequent in women referred to a hypertension clinic, and is associated with severe hypertension but not with evidence of end-organ damage.
Introduction
Most risk factors for hypertension are shared by men and women, such as obesity, salt intake, family history and alcoholic beverages consumption. Pregnant women, however, are at risk of presenting a sex-specific cause of hypertension, that is, pregnancy-induced hypertension. 1 Hypertensive disorders are among the most common complications during pregnancy and are a major cause of maternal mortality. 2 Hypertension affects 10% of pregnancies, particularly among primiparous women. 2, 3 Hypertension in pregnancy includes a spectrum of conditions classified as pre-eclampsia/eclampsia, chronic hypertension, pre-eclampsia superimposed on chronic hypertension and gestational hypertension. 3 In a Brazilian cohort of midpregnant women, 7.5% presented hypertensive disorders and 2.3% had pre-eclampsia/eclampsia. 4 The occurrence of such disorders in a specific period of women lives may have consequences thereafter. The association between pre-eclampsia or hypertensive diseases of pregnancy and ensuing events, such as cardiovascular diseases, hypertension and mortality due to any cause, was shown in epidemiological studies. 1, 5, 6 Women with a history of hypertensive pregnancy should be counselled about their increased risk for both recurrent problems during pregnancy and future cardiovascular disease, and they should be monitored closely for the risk factors involving the two conditions. 3, 7 There are two approaches to studying the question of whether hypertensive diseases of pregnancy are associated with a higher incidence of hypertension in later life: to follow women who were evaluated during the pregnancy and followed to determine whether the incidence of hypertension differs among the parous population who had or did not have hypertensive diseases of pregnancy. The second approach is to investigate the history of hypertensive diseases of pregnancy among patients already with hypertension. The former method is preferable, in that diagnosis of hypertensive diseases of pregnancy is more likely to have been performed on a consistent basis. However, the latter method is more likely to represent the clinical practice of non-obstetric physicians, to whom women are referred often many years after a pregnancy. Our report comes from such a setting. To our knowledge, there is no systematic evaluation about the proportion of women who refer an earlier episode of pregnancy-related hypertension and the consequences of such episodes in a clinical setting. The aim of this study was therefore to investigate the prevalence of the recall of a pregnancy-related hypertension episode by women referred to an outpatient hypertensive clinic and the association between the occurrence of hypertension in the pregnancy with the severity of later hypertension and with evidence of end-organ damage.
Materials and methods
Our data come from a prospectively planned cohort study of patients with hypertension in the hypertension clinic of the Divisions of Cardiology and Clinical Pharmacology (Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil), approved by the Institution's Review and Ethics Committee. Patients for this analysis were included in the cohort between 1989 and 2000. Participants were referred by other services of our hospital or by the primary care system of our state, and included the full spectrum of hypertension presentation. The majority was already being treated with blood pressure-lowering drugs. Details of its design and data collection have been reported elsewhere. [8] [9] [10] During baseline evaluation, patients answered to an extensive questionnaire and were submitted to a detailed physical examination. The classification of blood pressure, according to the VII Joint National Committee recommendations, 11 was based on the average of six blood pressure measurements taken in three visits separated by intervals of 1-2 weeks. The diagnosis of hypertension and its classification were established during the first visit when blood pressure was within normal levels on antihypertensive therapy, in patients with severe hypertension and in patients with clinical consequences of high blood pressure. Secondary hypertension was investigated in the presence of clinical suspicion on the basis of standard recommendations.
Sitting blood pressure was determined twice at 2-min interval, after 5 min of rest, through indirect auscultatory method, using mercury or aneroid sphygmomanometers with a standard cuff (12 Â 23 cm), keeping the arm at the fourth intercostal level. In patients with arm circumference 432 cm a large cuff (15 Â 33 cm) was used. The first phase of Korotkoff sounds was considered as systolic (SBP) and the fifth phase as diastolic blood pressure (DBP).
The occurrence of pregnancy-related hypertension was characterized by the response of patients to a specific question of the questionnaire: 'did you have any hypertensive problems during any of your pregnancies?' The type of hypertensive disorder was not specified, and therefore all analyses were based on the occurrence of episodes of unspecified pregnancy-related hypertension. Current or past use of oral contraceptives was recorded as informed by patient. The presence of end-organ damage was defined as creatinine level higher than 1.2 mg per 100 ml; left ventricular hypertrophy recorded on electrocardiogram (defined as R in leads V5 or 6 plus S-wave in lead V1X35 mm in a direct analysis) 12 or by colour Doppler echocardiogram, and diagnoses of optic fundi abnormality by direct fundoscopy (arteriolar narrowing, abnormal arteriovenous crossing, retinal haemorrhages or exudates).
Blood pressure and other continuous variables were presented as mean ± s.d. in patients with and without a history of hypertensive disorders and were compared using Student's t-test for independent samples. Categorical variables were compared using w 2 -test. A logistic regression model was used to explore the association between different variables, including the history of hypertensive disorders during pregnancy, with severity of hypertension (stage 2 of the classification of JNC VII-SBPX160 mm Hg or DBPX100 mm Hg) as outcome. An a-level of 0.05 was regarded as significant and 95% CIs were calculated when appropriate.
Results
A total of 768 women out of 936 were evaluated in this analysis. Of these, 168 were excluded because of missing data. Women studied consisted predominantly of the low-income group with low-to-moderate hypertension of long duration. Their mean age, SBP, DBP and body mass index (BMI) were 51.6 ± 12.7 years, 158.2 ± 26.6 mm Hg, 93.8±14.3 mm Hg and 29.4±5.6 kg/m 2 , respectively. In this sample, 20.7% were classified as non-white and 48.6% were classified at stage 2 of the JNC VII. Considering isolated SBP or DBP alteration, 15.4% were at pre-hypertension values (27 were not on antihypertensive therapy). In total, 253 (32.9%) patients self-reported having had hypertension during pregnancy. Table 1 compares the characteristics of the patients classified by the occurrence of an episode of hypertension during pregnancy. Patients without a history of hypertension during pregnancy were older, whereas women with a history of hypertension during pregnancy had higher BMI, higher prevalence of past or current oral contraceptives use and had more frequently a non-white skin colour. DBP was significantly higher in women with an episode of pregnancy-related hypertension. There was no association of history of hypertension during pregnancy with end-organ damage ( Table 2) . Figure 1 shows the results of the logistic regression analysis with hypertension at stage 2 as dependent variable. Pregnancy-related hypertension Pregnancy-related hypertension LB Moreira et al was significantly associated with more severe hypertension (OR: 1.6) independent of age, BMI, skin colour and past or present use of oral contraceptives.
Discussion
Clinical data that are sex-specific may play an important role in clinical evaluation of hypertensive patients. Women using oral contraceptives have a significant increase in DBP and poor blood pressure control, independent of age, weight and antihypertensive drug treatment. 8, 13 Use of hormone replacement therapy was not recorded in our cohort, but it is not expected to increase significantly the blood pressure.
14 Our findings showed that a history of hypertension in the pregnancy is another sexspecific event, which occurred in about a third of hypertensive women referred to hypertension clinic. This proportion is higher than those presented by epidemiologic studies and reflects a selection bias resulting from the referral to a specialized clinic. The reliability of the information about the occurrence of hypertension during pregnancy is probably high in view of the importance of pregnancy and its complications in the woman's life, but could not be checked in our database. Yawn et al. 15 described a reasonable agreement between maternal reports of the delivery and medical records 10-15 years after the birth, with an overall k-statistics of 0.49, despite that they investigated only episodes of pre-eclampsia and not pregnancy-induced hypertension. The recall in the study of Buka et al. 16 was not high. Therefore, the ability of women to recall the occurrence of hypertension during pregnancy is uncertain, but we believe that it can provide at least a rough estimative of a remote hypertensive disorder during pregnancy. The type of hypertensive disorder was not specified and therefore we could not explore the risk associated with a particular disorder.
The occurrence of an episode of pregnancyrelated hypertension was significantly and independently associated with a more severe classification in their current hypertensive status but not with an evidence of end-organ damage. Large populationbased retrospective cohort study with more than one million in Canada showed a significant association between a maternal placenta syndromepre-eclampsia, gestational hypertension, placental The total does not sum 768 due to missing data. Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure. Pregnacy-related hypertension Figure 1 The association between the recall of hypertension during pregnancy and severity of hypertension (stage 2).
Pregnancy-related hypertension LB Moreira et al abruption or placental infarction-with the incidence of cardiovascular disease (adjusted hazard ratio of 2.0, 95 CI%: 1.7-2.2). The risk was significantly more pronounced when the traditional risk factors where combined. 5 Bellamy et al., 1 in a meta-analysis of prospective and retrospective studies including more than three million women, also showed a positive association between preeclampsia and ischaemic heart disease or stroke after a follow-up of 11.7 and 10.4 years, respectively. For future hypertension, the relative risk was 3.70 (95% CI: 2.70-5.05) after 14.1 years of follow-up. An analysis including only pregnancy-induced hypertension also showed the same positive association. No increase in risk of any cancer was found, but overall mortality increased 17 years after preeclampsia (RR: 1.49; 95% CI: 1.05-2.14).
The underlying mechanism for the remote effects of pre-eclampsia or other pregnancy hypertensive disorders is complex and probably multifactorial. Many risk factors are shared by cardiovascular disease and pre-eclampsia, including endothelial dysfunction, obesity, hypertension, hyperglycaemia, insulin resistance and dyslipidaemia. It has been proposed that the metabolic syndrome may be a possible underlying mechanism common to cardiovascular disease and pre-eclampsia. 3, 7, 17 Our data showed that the proportion of hypertensive women who recall an earlier episode of hypertension during pregnancy is high in a referral clinic. These patients were younger than the patients without such history, suggesting that the hypertensive episode during pregnancy may have anticipated the development of hypertension. Besides, this simple information obtained from the medical history was significantly associated with a more severe stage of hypertension, independent from age, BMI and the use of oral contraceptives. This higher proportion of patients with severe hypertension among patients with an earlier episode of pregnancy-related hypertension was not accompanied by a higher frequency of end-organ damage. This fact reflects probably the younger age of the women with such episodes, without enough time to developing end-organ damage. The association of minor optic fundi abnormalities detected by direct ophthalmoscopy with the severity of hypertension, however, was weak in this cohort, as we had shown earlier. [18] [19] Our study has some limitations that deserve mention. The possibility of a recall bias was discussed earlier but cannot be fully discarded. An attempt to cross-check the information of an episode of pregnancy-related hypertension in the records of patients failed owing to small number of women who gave childbirth in our institution. In view of our study design, we could not also investigate potential mechanisms linking hypertension in the pregnancy with severe hypertension later on. We were also not able to distinguish the different disorders that express by hypertension in the pregnancy. The fact that our patients had mostly low income should take into account when considering the external validity of our findings. And finally, the evaluation of end-organ damage was restricted to only three systems, without using more sophisticated methods of evaluation. The major strength of our paper, however, was the detection, without a special interest in women's health, of a strong and independent association between a history of hypertension in the pregnancy and resistant hypertension in a clinical setting. This finding has clinical application, as it may demand a special attention to patients who report hypertension in the pregnancy, to detect precociously severe hypertension or unmasks a latent hypertension tendency in some women.
In conclusion, we showed that pregnancy-related hypertension is frequent in women referred to a hypertension clinic, and that it is a risk factor for the occurrence of severe hypertension. This finding supports the concept that hypertension in pregnancy may be an emerging sex-specific risk factor for cardiovascular disease.
